Treatment of short bowel syndrome patients with...

Details Treatment of short bowel syndrome patients with... Treatment of short bowel syndrome patients with...

A - Human Necessities

61

K

A61K 38/26 (2006.01) C07K 14/605 (2006.01)

Patent

CA 2585482

Intestinal absorption is enhances in short bowel syndrome patients presenting with colon-in continuity by treatment with GLP-2 receptor agonist, such as teduglutide.

Selon l'invention, l'absorption intestinale est améliorée chez les patients atteints du syndrome de l'intestin court présentant un colon en continuité par traitement avec un agoniste récepteur GLP-2, tel que du téduglutide.

Affiliated with

Also associated with

Rating

Treatment of short bowel syndrome patients with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of short bowel syndrome patients with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of short bowel syndrome patients with... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1623307